SARS-CoV-2 感染表现为 ST 段抬高型心肌梗死。
SARS-COV-2 infection presenting as ST-elevationmyocardial infarction.
机构信息
Department of Medicine, Division of Cardiology, Montefiore Health System, Albert Einstein College of Medicine, New York, New York, USA.
出版信息
Catheter Cardiovasc Interv. 2021 Feb 15;97(3):E339-E342. doi: 10.1002/ccd.28974. Epub 2020 May 30.
Abstract
We describe a patient presenting with chest discomfort, anterolateral ST elevation, and developing acute cardiogenic shock secondary to SARS-COV-2infection-patient zero presenting to our institution's cardiac catheterization laboratory. The emergent presentation with limited clinical information led to exposure of personnel. The diagnosis was complicated by two negative tests for SARS-COV-2, and high-clinical suspicion from the patient's occupational history led to additional testing in order to confirm the diagnosis.
摘要
我们描述了一位以胸痛、前外侧 ST 段抬高为表现，并因 SARS-CoV-2 感染发展为急性心源性休克的患者——我们机构的心脏导管实验室的首例患者。由于有限的临床信息，紧急就诊导致了人员暴露。由于 SARS-CoV-2 的两次检测均为阴性，且患者的职业史高度提示该病毒，因此该诊断变得复杂，并进行了额外的检测以确认诊断。
相似文献
1
SARS-COV-2 infection presenting as ST-elevationmyocardial infarction.SARS-CoV-2 感染表现为 ST 段抬高型心肌梗死。
Catheter Cardiovasc Interv. 2021 Feb 15;97(3):E339-E342. doi: 10.1002/ccd.28974. Epub 2020 May 30.
2
COVID-19 complicated by ST-segment elevation myocardial infarction in a 29-year-old patient.一名 29 岁患者合并 ST 段抬高型心肌梗死的 COVID-19。
Catheter Cardiovasc Interv. 2021 Feb 1;97(2):267-271. doi: 10.1002/ccd.29102. Epub 2020 Jul 16.
3
Management of a patient presenting with anterior STEMI with concomitant COVID-19 infection early in the course of the U.S. pandemic.美国大流行早期伴 COVID-19 感染的前壁 ST 段抬高型心肌梗死患者的处理。
Catheter Cardiovasc Interv. 2021 Feb 15;97(3):E333-E338. doi: 10.1002/ccd.28967. Epub 2020 May 29.
4
Transient ST-segment elevation in coronavirus disease-2019.2019冠状病毒病中的短暂性ST段抬高
J Cardiovasc Med (Hagerstown). 2021 May 1;22(5):417-419. doi: 10.2459/JCM.0000000000001075.
5
Delays in Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction Patients Presenting With Cardiogenic Shock.ST 段抬高型心肌梗死合并心原性休克患者行直接经皮冠状动脉介入治疗的延误。
JACC Cardiovasc Interv. 2018 Sep 24;11(18):1824-1833. doi: 10.1016/j.jcin.2018.06.030.
6
Patient and Provider Risk in Managing ST-Elevation Myocardial Infarction During the COVID-19 Pandemic: A Decision Analysis.在 COVID-19 大流行期间管理 ST 段抬高型心肌梗死的患者和提供者风险：决策分析。
Circ Cardiovasc Interv. 2020 Nov;13(11):e010027. doi: 10.1161/CIRCINTERVENTIONS.120.010027. Epub 2020 Nov 10.
7
A case of influenza type a myocarditis that presents with ST elevation MI, cardiogenic shock, acute renal failure, and rhabdomyolysis and with rapid recovery after treatment with oseltamivir and intra-aortic balloon pump support.一例甲型流感心肌炎患者，表现为ST段抬高型心肌梗死、心源性休克、急性肾衰竭和横纹肌溶解，经奥司他韦治疗及主动脉内球囊反搏支持后迅速康复。
Cardiovasc Revasc Med. 2018 Jan;19(1 Pt A):37-42. doi: 10.1016/j.carrev.2017.04.017. Epub 2017 May 2.
8
Acute Perimyocarditis - an ST-Elevation Myocardial Infarction Mimicker: A Case Report.急性心肌炎——酷似 ST 段抬高型心肌梗死的一种疾病：病例报告。
Am J Case Rep. 2022 Nov 14;23:e936985. doi: 10.12659/AJCR.936985.
9
A Review of ST-Elevation Myocardial Infarction in Patients with COVID-19.新型冠状病毒肺炎合并 ST 段抬高型心肌梗死的研究进展
Heart Fail Clin. 2023 Apr;19(2):197-204. doi: 10.1016/j.hfc.2022.08.007.
10
Fulminant myocarditis and cardiogenic shock during SARS-CoV-2 infection.新型冠状病毒感染期间的暴发性心肌炎和心源性休克
Med Clin (Barc). 2020 Nov 27;155(10):463-464. doi: 10.1016/j.medcli.2020.07.010. Epub 2020 Jul 28.
引用本文的文献
1
Presentation and outcome of myocardial infarction with non-obstructive coronary arteries in coronavirus disease 2019.2019冠状病毒病合并非阻塞性冠状动脉心肌梗死的临床表现及预后
World J Crit Care Med. 2022 May 9;11(3):129-138. doi: 10.5492/wjccm.v11.i3.129.
2
Acute myocardial infarction in COVID-19 patients. A review of cases in the literature.COVID-19患者的急性心肌梗死。文献病例综述。
Arch Med Sci Atheroscler Dis. 2021 Sep 20;6:e169-e175. doi: 10.5114/amsad.2021.109287. eCollection 2021.
3
The Challenges of ST-Elevation Myocardial Infarction in COVID-19 Patients.COVID-19患者中ST段抬高型心肌梗死的挑战
Case Rep Cardiol. 2021 Aug 21;2021:9915650. doi: 10.1155/2021/9915650. eCollection 2021.
4
Thrombosis Management and Challenges in COVID-19 Patients Presenting with Acute Coronary Syndromes.新冠病毒肺炎合并急性冠脉综合征患者的血栓形成管理与挑战
Heart Views. 2020 Jul-Sep;21(3):195-208. doi: 10.4103/HEARTVIEWS.HEARTVIEWS_143_20. Epub 2020 Oct 13.
本文引用的文献
1
A Call to Action: The Need for Autopsies to Determine the Full Extent of Organ Involvement Associated With COVID-19.行动呼吁：需要进行尸检以确定与 COVID-19 相关的器官受累的全部程度。
Chest. 2020 Jul;158(1):43-44. doi: 10.1016/j.chest.2020.03.060. Epub 2020 Apr 10.
2
COVID-19 Autopsies, Oklahoma, USA.美国俄克拉荷马州的 COVID-19 尸检。
Am J Clin Pathol. 2020 May 5;153(6):725-733. doi: 10.1093/ajcp/aqaa062.
3
Myocardial localization of coronavirus in COVID-19 cardiogenic shock.COVID-19 心原性休克中冠状病毒的心肌定位。
Eur J Heart Fail. 2020 May;22(5):911-915. doi: 10.1002/ejhf.1828. Epub 2020 Apr 11.
4
Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From the ACC's Interventional Council and SCAI.新型冠状病毒肺炎（COVID-19）大流行期间的心导管实验室考量：来自美国心脏病学会介入委员会和心血管造影和介入学会
J Am Coll Cardiol. 2020 May 12;75(18):2372-2375. doi: 10.1016/j.jacc.2020.03.021. Epub 2020 Mar 19.
5
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.洛匹那韦-利托那韦治疗成人重症 COVID-19 患者的临床试验。
N Engl J Med. 2020 May 7;382(19):1787-1799. doi: 10.1056/NEJMoa2001282. Epub 2020 Mar 18.
6
COVID-19 and the cardiovascular system.新型冠状病毒肺炎与心血管系统。
Nat Rev Cardiol. 2020 May;17(5):259-260. doi: 10.1038/s41569-020-0360-5.
7
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
8
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
Zotero 插件